Daniel Layish

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 126 citations · Full text

Pharmacy, Pharmacotherapy, Good Clinical Practice +8

Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism

H. Dirk Sostman, Daniel Layish, Victor F. Tapson et al. · Journal of Magnetic Resonance Imaging · 1996 · 92 citations

Medicine, Radiology, Diagnostic Imaging +7

Diagnostic Yield of Bronchoscopies After Isolated Lung Transplantation

Maher A. Baz, Daniel Layish, Joseph A. Govert et al. · CHEST Journal · 1996 · 66 citations

Medicine, Internal Medicine, Surgery +9

Lung Transplantation for Williams-Campbell Syndrome

Scott M. Palmer, Daniel Layish, Peter S. Kussin et al. · CHEST Journal · 1998 · 25 citations

Medicine, Clinical Sciences, Pediatrics +8